News & Updates
Filter by Specialty:

COVID-19 infection in early pregnancy ups risk of stillbirth
Pregnant women who contract COVID-19 during early and mid-pregnancy are at risk of stillbirth, but this risk may not be present when infection occurs at any time during the third trimester or before delivery, as reported in a study.
COVID-19 infection in early pregnancy ups risk of stillbirth
08 Mar 2023
FIB-4 changes linked to risk of cirrhosis, HCC in NAFLD
Longitudinal changes in fibrosis-4 (FIB-4) score are strongly predictive of progression to cirrhosis and hepatocellular carcinoma (HCC) in patients with nonalcoholic fatty liver disease (NAFLD), reveals a study.
FIB-4 changes linked to risk of cirrhosis, HCC in NAFLD
08 Mar 2023
Mobile app captures symptoms, biometrics of bladder cancer patients after cystectomy
Patients with bladder cancer who underwent radical cystectomy may benefit from the use of smartphones and wearable technology to monitor their symptoms as well as biometric data, according to a recent study.
Mobile app captures symptoms, biometrics of bladder cancer patients after cystectomy
08 Mar 2023
CheckMate 274 follow up data boost nivolumab potential for high-risk bladder cancer
In the extended follow up of the phase III CheckMate 274 trial, nivolumab continued to show benefit for patients with muscle-invasive urothelial carcinoma (MIUC; bladder, ureter, or renal pelvis) who were at high risk for recurrence following bladder resection.
CheckMate 274 follow up data boost nivolumab potential for high-risk bladder cancer
08 Mar 2023
Post-treatment neutrophil, lymphocyte counts offer clues to Hodgkin’s lymphoma prognosis
For patients with Hodgkin’s lymphoma who have completed a first-line chemotherapy regimen that includes doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD), neutrophil and lymphocyte counts are predictive of disease prognosis, as reported in a study from Singapore.
Post-treatment neutrophil, lymphocyte counts offer clues to Hodgkin’s lymphoma prognosis
08 Mar 2023
Longer time in BP target protects against adverse cardiovascular events in diabetes
For patients with hypertension and diabetes, longer time spent in blood pressure (BP) target range helps lower the risk of cardiovascular disease, according to a study.